Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: Results of the IMPACT SHPT study

Markus Ketteler, Kevin J. Martin*, Myles Wolf, Michael Amdahl, Mario Cozzolino, David Goldsmith, Amit Sharma, Steven Marx, Samina Khan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: Results of the IMPACT SHPT study'. Together they form a unique fingerprint.

Medicine & Life Sciences